Cargando…

Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation

OBJECTIVE: The achievement of the optimal control of the disease is of cardinal importance in asthma treatment. As the control of the disease is sustained the medication should be gradually reduced and then stopped. Nevertheless, the discontinuation of asthma medication may lead to loss of disease c...

Descripción completa

Detalles Bibliográficos
Autores principales: Spyroglou, Ioannis I., Spöck, Gunter, Rigas, Alexandros G., Paraskakis, E. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069881/
https://www.ncbi.nlm.nih.gov/pubmed/30064478
http://dx.doi.org/10.1186/s13104-018-3621-1
_version_ 1783343591313113088
author Spyroglou, Ioannis I.
Spöck, Gunter
Rigas, Alexandros G.
Paraskakis, E. N.
author_facet Spyroglou, Ioannis I.
Spöck, Gunter
Rigas, Alexandros G.
Paraskakis, E. N.
author_sort Spyroglou, Ioannis I.
collection PubMed
description OBJECTIVE: The achievement of the optimal control of the disease is of cardinal importance in asthma treatment. As the control of the disease is sustained the medication should be gradually reduced and then stopped. Nevertheless, the discontinuation of asthma medication may lead to loss of disease control and eventually to an exacerbation of the disease. The goal of this paper is to examine the performance of Bayesian network classifiers in predicting asthma exacerbation based on several patient’s parameters such as objective measurements and medical history data. RESULTS: In this study several Bayesian network classifiers are presented and evaluated. It is shown that the proposed semi-naive network classifier with the use of Backward Sequential Elimination and Joining algorithm is able to predict if a patient will have an exacerbation of the disease after his last assessment with 93.84% accuracy and 90.9% sensitivity. In addition, the resulting structure and the conditional probability tables give a clear view of the probabilistic relationships between the used factors. This network may help the clinicians to identify the patients who are at high risk of having an exacerbation after stopping the medication and to confirm which factors are the most important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3621-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6069881
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60698812018-08-06 Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation Spyroglou, Ioannis I. Spöck, Gunter Rigas, Alexandros G. Paraskakis, E. N. BMC Res Notes Research Note OBJECTIVE: The achievement of the optimal control of the disease is of cardinal importance in asthma treatment. As the control of the disease is sustained the medication should be gradually reduced and then stopped. Nevertheless, the discontinuation of asthma medication may lead to loss of disease control and eventually to an exacerbation of the disease. The goal of this paper is to examine the performance of Bayesian network classifiers in predicting asthma exacerbation based on several patient’s parameters such as objective measurements and medical history data. RESULTS: In this study several Bayesian network classifiers are presented and evaluated. It is shown that the proposed semi-naive network classifier with the use of Backward Sequential Elimination and Joining algorithm is able to predict if a patient will have an exacerbation of the disease after his last assessment with 93.84% accuracy and 90.9% sensitivity. In addition, the resulting structure and the conditional probability tables give a clear view of the probabilistic relationships between the used factors. This network may help the clinicians to identify the patients who are at high risk of having an exacerbation after stopping the medication and to confirm which factors are the most important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13104-018-3621-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-31 /pmc/articles/PMC6069881/ /pubmed/30064478 http://dx.doi.org/10.1186/s13104-018-3621-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Spyroglou, Ioannis I.
Spöck, Gunter
Rigas, Alexandros G.
Paraskakis, E. N.
Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation
title Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation
title_full Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation
title_fullStr Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation
title_full_unstemmed Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation
title_short Evaluation of Bayesian classifiers in asthma exacerbation prediction after medication discontinuation
title_sort evaluation of bayesian classifiers in asthma exacerbation prediction after medication discontinuation
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069881/
https://www.ncbi.nlm.nih.gov/pubmed/30064478
http://dx.doi.org/10.1186/s13104-018-3621-1
work_keys_str_mv AT spyroglouioannisi evaluationofbayesianclassifiersinasthmaexacerbationpredictionaftermedicationdiscontinuation
AT spockgunter evaluationofbayesianclassifiersinasthmaexacerbationpredictionaftermedicationdiscontinuation
AT rigasalexandrosg evaluationofbayesianclassifiersinasthmaexacerbationpredictionaftermedicationdiscontinuation
AT paraskakisen evaluationofbayesianclassifiersinasthmaexacerbationpredictionaftermedicationdiscontinuation